- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01556893
Creating LASIK Flaps With the LenSx Femtosecond Laser
Prospective, Single-center Clinical Trial of Subjects Scheduled to Undergo LASIK Surgery Requiring an Initial Corneal Flap.
This will be a prospective, single-center clinical trial of up to 50 eyes of subjects scheduled to undergo LASIK surgery requiring an initial corneal flap. Subjects will be screened for eligibility.
Subjects will undergo LASIK surgery using the LenSx Laser to create the corneal flap prior to excimer laser treatment.
Subjects will be evaluated intraoperatively to assess the ease of lifting the flaps, the stromal bed quality, and the amount of opaque bubble layer. All patients will be followed with routine vision exams for 3 months postoperatively to evaluate changes in visual acuity, manifest refraction, slit lamp examination, and endothelial cell counts.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Budapest, Hungary, 1085
- Department of Ophthalmology, Semmelweis University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Must have myopia or hyperopia eligible for femtosecond initiated LASIK surgery
- Must be over 18 years of age
- Must have visual acuity correctable to at least 20/25 in both eyes
- If subject is a contact lens wearer, discontinuation of contact lens wear prior to preoperative exam (2 weeks prior for soft contact lenses, 4 weeks prior for rigid gas permeable contact lenses, and 8 weeks prior for hard contact lenses)
- Must be willing and able to return for scheduled follow up examinations through 3 months after surgery
- Must sign and be given a copy of the written Informed Consent form
- Postoperative refractive target is emmetropia
Exclusion Criteria:
- Known sensitivity to planned study concomitant medications
- Participation in any other ophthalmic drug or device clinical trial during the time of this clinical investigation
- Presenting any contraindications to femtosecond initiated LASIK
- Corneal thickness values that will result in residual bed less than 280 microns when flap resection and excimer ablation are calculated
- Irregular astigmatism, based on Investigator's judgment
- Undergoing monovision LASIK
- Pregnant, lactating or plan to become pregnant during the course of this study
- For bilateral second study eyes only: The surgeon shall not proceed with the second eye until the 1 week exam of the first eye shows no vision threatening complications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: LASIK Flap Arm
This is a single arm study.
|
The LenSx laser system is a femtosecond laser that has received 510(k) clearance for anterior capsulotomy during cataract surgery (K082947), laser phacofragmentation during cataract surgery (K094052) and for use in the creation of a single and multi-plane arc cut/incisions in the cornea (K092647).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ease of Lifting Flaps
Time Frame: Operative
|
0 - Unable to lift flap
|
Operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stromal Bed Quality
Time Frame: Operative
|
0 - very rough 1- moderately rough 2 - rough 3 - smooth 4 - moderately smooth 5 - very smooth (Scale) |
Operative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CS-004f
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on LenSx Laser
-
LenSx Lasers Inc.Completed
-
Alcon ResearchCompleted
-
Alcon, a Novartis CompanyCompletedIntumescent Cataract
-
LenSx Lasers Inc.CompletedCataract | Corneal DiseaseUnited States
-
Steve H. Linn, ODCompletedCortical Cataract | Posterior Subcapsular Cataract | Nuclear Sclerosis of the LensUnited States
-
Alcon ResearchCompletedMyopia | HyperopiaUnited States
-
Gainesville Eye AssociatesAlcon, a Novartis CompanyCompleted
-
Alcon ResearchCompleted
-
Manchester University NHS Foundation TrustTopcon Corporation; Optos, PLCWithdrawnDiabetic Macular OedemaUnited Kingdom